Related Experiment Videos
A copula approach for detecting prognostic genes associated with survival outcome in microarray studies
Kouros Owzar1, Sin-Ho Jung, Pranab Kumar Sen
1Department of Biostatistics and Bioinformatics, Duke University Medical Center, Durham, North Carolina 27705, USA. kouros.owzar@duke.edu
Biometrics
|May 9, 2007
Summary
This study introduces a new statistical method for cancer research to identify key genes linked to patient outcomes. The approach effectively handles censored data and adjusts for multiple testing in gene microarray analysis.
Area of Science:
- Biostatistics
- Bioinformatics
- Cancer Genomics
Background:
- Identifying gene panels associated with clinical outcomes (e.g., time-to-death) in cancer is crucial but challenging.
- Gene microarray experiments generate large datasets, requiring methods to discover a small subset of relevant genes.
- Time-to-event endpoints in clinical studies are often subject to censoring.
Purpose of the Study:
- To develop a statistical method for discovering gene panels associated with clinical outcomes in cancer.
- To address challenges of censoring and multiplicity adjustment in gene microarray data analysis.
- To quantify and estimate the association between gene expression and clinical outcomes using a semiparametric approach.
Main Methods:
- Utilized a semiparametric approach employing copulas to model pairwise associations.
- Incorporated the censoring mechanism directly into the statistical model.
- Applied statistical adjustment for multiplicity to control error rates in gene discovery.
Main Results:
- The proposed method demonstrated effectiveness in simulation studies.
- The approach was successfully applied to a lung cancer case study.
- Successfully identified gene expression associations with clinical outcomes while managing censoring and multiplicity.
Conclusions:
- The developed method provides a robust framework for gene discovery in cancer clinical studies.
- The copula-based approach effectively handles censored time-to-event data and multiplicity.
- This method enhances the ability to identify biologically relevant gene panels for predicting cancer outcomes.
Related Concept Videos
Cancer Survival Analysis
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
DNA Microarrays
Microarrays are high-throughput and relatively inexpensive assays that can be automated to analyze large quantities of data at a time. They are used in genome-wide studies to compare gene or protein expression under two varied conditions, such as healthy and diseased states. Microarrays consist of glass or silica slides on which probe molecules are covalently attached through surface functionalization. Most commonly, the slides are prepared through the chemisorption of silanes to silica...
Comparing the Survival Analysis of Two or More Groups
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and Cox...
Kaplan-Meier Approach
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...